This half day course is designed for those who want to understand the fundamentals of pharmaceutical commercialisation and how early-stage companies should approach it. 

The course aims to cover the following:
•    What exactly is commercialisation
•    When should companies start thinking about it
•    Demystifying sales, marketing and market access
•    Why a commercial plan matters for investors/partners
•    How R&D and commercial teams can work better together
•    Why a commercial mindset is critical for everyone to have
•    Key commercial questions executives should be able to answer 
•    What commercial knowledge you need to successfully negotiate

About the speaker:

Ed Corbett has spent 25 years working in the pharma industry as both an executive and consultant. He has held global and UK commercial roles at both GSK and Merck & Co., and has launched 4 brands across multiple therapy areas.
He currently leads a global consulting team for Branding Science Group, and uses behavioural science to create great brands that make difference to HCPs and the patients they support.
He is passionate about the value that great sales and marketing bring to the pharmaceutical industry and is a industry thinker, author and speaker.

By the end of the course, attendees will have a better understanding of the key principles of commercialisation, be able to hold productive conversations with potential investors and create assets that deliver maximum value.

Costs:
One Nucleus Gold: £52.50 + VAT
One Nucleus Silver: £63.75 + VAT
Non-members: £75 + VAT